Literature DB >> 11169382

The hammerhead ribozyme.

F Eckstein1, B Bramlage.   

Abstract

The hammerhead ribozyme is an intriguing RNA molecule with the ability to serve as a catalyst to cleave sequence-specifically RNA molecules in an intermolecular reaction. Preferentially Mg(2+) is required for optimal activity by inducing the catalytically competent conformation and by possibly acting as an acid-base catalyst. Even though the three-dimensional structure has been elucidated details of the structure-function relationship and of the mechanism remain unanswered. The hammerhead ribozyme has stimulated the concept of the sequence-specific cleavage of mRNAs intracellularly and thus to inhibit gene expression by preventing translation. This represents an area of considerable interest as it has the potential for the development of drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11169382     DOI: 10.1002/1097-0282(1999)52:3<147::AID-BIP40>3.0.CO;2-I

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  4 in total

1.  The reactivity of phosphodiester bonds within linear single-stranded oligoribonucleotides is strongly dependent on the base sequence.

Authors:  Ulla Kaukinen; Sari Lyytikäinen; Satu Mikkola; Harri Lönnberg
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

2.  Coupling of fast and slow modes in the reaction pathway of the minimal hammerhead ribozyme cleavage.

Authors:  Ravi Radhakrishnan
Journal:  Biophys J       Date:  2007-06-01       Impact factor: 4.033

3.  A continuous kinetic assay for RNA-cleaving deoxyribozymes, exploiting ethidium bromide as an extrinsic fluorescent probe.

Authors:  Davide Ferrari; Alessio Peracchi
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

4.  Structure and binding of Mg(II) ions and di-metal bridge complexes with biological phosphates and phosphoranes.

Authors:  Evelyn Mayaan; Kevin Range; Darrin M York
Journal:  J Biol Inorg Chem       Date:  2004-08-20       Impact factor: 3.358

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.